Central Precocious Puberty: Treatment with Triptorelin 11.25 mg

Table 2

Biochemical data at baseline and 3, 6, and 12 months of quarterly triptorelin 11.25 mg.

	baseline	3 months	6 months	12 months
Basal LH,  IU/L	1.9±1.6	0.3±0.2	0.4±0.4	0.4±0.2
Peak LH,  IU/L	25.7±16.5	0.9±0.5	1.0±0.5	1.0±0.5
Peak LH < 3 IU/L	—	17/17	17/17	17/17
Basal FSH,  IU/L	4.1±2.2	0.9±0.5	1.1±0.5	1.5±0.8
Peak FSH,  IU/L	11.7±4.7	1.3±0.6	1.3±0.6	1.9±0.9
17β estradiol, pmol/L°	58.0±45.5	30.8±7.7	27.8±12.1	34.1±12.1
17β estradiol < 70 pmol/L°	11/16	16/16	16/16	16/16

°data related to the 16 girls enrolled in the study. °Peak < 2 IU/L 17/47 a M3, M6, M12.